Skip to main content
Signal8

HILLHOUSE INVESTMENT MANAGEMENT, LTD.

SEC insider (Form 3/4/5 filer). CIK 0001510589. 10% Owner at ArriVent BioPharma, Inc. (AVBP). 1 reported Form 4/5 transaction since Sep 2024; latest on Dec 10, 2025. Located in GRAND CAYMAN, E9.

Companies HILLHOUSE INVESTMENT MANAGEMENT, LTD. has filed insider reports for

  • ArriVent BioPharma, Inc. (AVBP): 10% Owner
HILLHOUSE INVESTMENT MANAGEMENT, LTD. profile photo

HILLHOUSE INVESTMENT MANAGEMENT, LTD.

CIK: 0001510589

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ArriVent BioPharma, Inc. logo
AVBP

ArriVent BioPharma, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • ArriVent BioPharma, Inc. logo
    AVBP

    ArriVent BioPharma, Inc.

    Dec 10, 2025
    Sale
    Indirect
    555.6K shares at avg. $23.37$13.0M

1-1 of 1